Clinical impact of cerebral protection during transcatheter aortic valve implantation

Abstract

AbstractBackgroundEmbolization of debris can complicate transcatheter aortic valve implantation (TAVI) causing stroke. Cerebral embolism protection (CEP) devices can divert or trap debris.PurposeTo evaluate the efficacy of CEP during TAVI vs the standard procedure.Data SourcesPubMed, SCOPUS and DOAJ 1/01/2014–04/12/2023.Study SelectionRandomized and observational studies comparing CEP versus standard TAVI, according to PRISMA. Primary outcome: stroke. Secondary outcomes: death, bleeding, vascular access complications, acute kidney injury and infarct area.Data ExtractionTwo investigators independently assessed study quality and extracted data.Data SynthesisTwenty‐six articles were included (540.247 patients). The primary endpoint was significantly lower (RR = 0.800 95%CI:0.682–0.940; p = 0.007) with CEP. Similarly, death rates were significantly lower with CEP (RR = 0.610 95%CI:0.482–0.771; p < 0.001). No difference was found for bleeding (RR = 1.053 95%CI:0.793–1.398; p = 0.721), vascular complications (RR = 0.937 95%CI:0.820–1.070; p = 0.334) or AKI (RR = 0.982 95%CI:0.754–1.279; p = 0.891).ConclusionsUse of CEP during TAVI is associated with improved outcomes. Future studies will identify patients who benefit most from CEP.